Friday 30 October 2026 Export MODD’s income statement to Excel — free account

Modular Medical, Inc.

In the quarter to June 2026, EPS grew 67.0% and free cash flow fell 5.61%, each against the same quarter a year earlier.

1.78 0.06 +3.49%

Follow MODD

Alert me

Market cap: $16.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 16.33

Revenue —

Net Income (28.03)

Free Cash Flow (28.04)

Net Debt (3.92)

Current Ratio 3.25

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E —

P/S ratio 0.00

P/B ratio 0.90

Past 5Y EPS Growth —

This Y EPS Growth 38.46%

Next Y EPS Growth 18.75%

Next Y revenue growth —

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/B against its own 10 years 3.09%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities $m

	2024	2025	2026	Q'26
Cash	9	13	7	4
Receivables	—	—	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	10	14	8	5

	2024	2025	2026	Q'26
Payables	1	0	1	1
ST’ Debt	—	—	—	—
Other	—	—	—	—
	1	1	2	1

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	—
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	36.67%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY24 Estimate −5.11 Actual −6.91

−10.63 −9.07 −7.51 −5.95 −4.39

Q3 FY23 Beat +0.60

Q2 FY24 Met 0.00

Q3 FY24 Miss −1.80

Earnings per share against the consensus, by quarter
Quarter	Estimate	Reported	Result
Q3 FY23	−9.91	−9.31	Beat by 0.60
Q2 FY24	−5.71	−5.71	Met by 0.00
Q3 FY24	−5.11	−6.91	Miss by 1.80

EPS $

	Jun	Sep	Dec	Mar	Year
’26	(1.19)	—	—	—	—
’26	(3.60)	(4.20)	(3.30)	(1.95)	(12.36)
’25	(3.60)	(4.20)	(3.90)	(3.60)	(15.31)
’24	(6.61)	(5.71)	(6.91)	(4.69)	(23.42)
’23	(9.91)	(9.61)	(9.31)	(9.91)	(34.40)
’22	(22.98)	(20.81)	(22.82)	(15.62)	(82.28)
’21	(3.00)	(3.00)	(8.99)	(3.00)	(35.67)

Fiscal quarters ending in the months shown.

Revenue $m

	Year

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jun	Sep	Dec	Mar	Year
’26	(6)	—	—	—	—
’26	(5)	(5)	(7)	(6)	(24)
’25	(4)	(4)	(4)	(4)	(16)
’24	(3)	(3)	(4)	(4)	(14)
’23	(3)	(3)	(3)	(3)	(11)
’22	(2)	(3)	(2)	(3)	(10)
’21	(2)	(2)	(2)	(1)	(6)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jun	Sep	Dec	Mar	Year
’26	(7)	—	—	—	—
’26	(6)	(6)	(8)	(7)	(28)
’25	(4)	(4)	(5)	(5)	(18)
’24	(4)	(4)	(4)	(4)	(16)
’23	(3)	(3)	(3)	(4)	(13)
’22	(2)	(3)	(2)	(3)	(10)
’21	(2)	(2)	(2)	(1)	(6)

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	Trend	10 yrs	2027e	2028e	2029e	Next 3/yr
												Ten-year view		Analyst estimates Powerpack
Price, $
Price, $	Low	24.30	18.00	18.00	21.60	162.00	47.10	25.20	32.40	8.40	1.52		(26.5%)	‡‡‡‡	‡‡‡‡	‡‡‡‡	‡‡‡‡
	High	24.30	24.30	21.60	342.00	585.00	450.05	115.21	79.51	44.67	16.20		(4.4%)	‡‡‡‡	‡‡‡‡	‡‡‡‡	‡‡‡‡
People
People	Employees	—	—	6	13	20	25	38	40	54	51		+35.8%	‡‡‡‡	‡‡‡‡	‡‡‡‡	‡‡‡‡
	Revenue/emp, $m	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		n/m	‡‡‡‡	‡‡‡‡	‡‡‡‡	‡‡‡‡
Income, $m
Income, $m	Revenue	—	—	—	—	—	—	—	—	—	—		—	35	—	—	—
	Gross margin, %	—	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—		0.0 pt	Powerpack Modular Medical, Inc.’s next three years, line by line See the consensus for every other line: earnings, margins, cash flow, valuation and returns. Unlock estimates Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time. Also in Powerpack: every quarter, Excel exports, API & MCP access. Compare plans
	EBT	—	(1)	(3)	(5)	(7)	(19)	(14)	(17)	(19)	(28)		+60.0%
	EBT margin, %	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.0 pt
	Net income	—	(1)	(3)	(5)	(7)	(19)	(14)	(17)	(19)	(28)		+60.0%
	Depreciation	—	0	0	0	0	2	0	0	1	2		+133.4%
Per share, $
Per share, $	Revenue	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		n/m
	Earnings	—	(1.48)	(4.60)	(9.01)	(35.67)	(82.28)	(34.40)	(23.42)	(15.31)	(12.36)		+30.3%
	Cash flow	—	(1.78)	(3.27)	(6.88)	(28.57)	(45.26)	(27.32)	(18.72)	(12.75)	(10.40)		+24.7%
	Capex	—	(0.03)	(0.14)	(0.44)	(0.53)	(0.24)	(4.06)	(2.28)	(2.02)	(1.72)		+63.0%
	Free cash flow	—	(1.82)	(3.41)	(7.32)	(29.10)	(45.50)	(31.39)	(21.00)	(14.77)	(12.12)		+26.8%
	Book value	—	9.73	11.72	4.84	(6.17)	38.98	12.60	15.48	13.85	5.67		(6.5%)
	Shares, m	—	0	1	1	0	0	0	1	1	2		+22.7%
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	—	—	—	—	—		—
	P/S	—	—	—	—	—	—	—	—	—	—		—
	P/B	—	—	—	—	—	—	—	—	—	—		—
	EV/Sales	—	—	—	—	—	—	—	—	—	—		—
	EV/FCF	—	—	—	—	—	—	—	—	—	—		—
Cash, $m
Cash, $m	Operating cash flow	—	(1)	(2)	(4)	(6)	(10)	(11)	(14)	(16)	(24)		+53.0%
	Capex	—	0	0	0	0	0	(2)	(2)	(2)	(4)		+100.1%
	Free cash flow	—	(1)	(2)	(4)	(6)	(10)	(13)	(16)	(18)	(28)		+55.6%
Balance, $m
Balance, $m	Working capital	—	4	6	3	(2)	8	3	8	12	6		+3.5%
	Total debt	—	—	—	0	3	0	2	—	—	—		+78.7%
	Net debt	—	(4)	(7)	(3)	(1)	(9)	(4)	(9)	(13)	(7)		+6.2%
	Shareholders’ equity	—	4	6	3	(1)	9	5	12	17	13		+14.7%
Returns, %
Returns, %	ROA	—	(12.00)	(46.23)	(101.24)	(241.63)	(308.12)	(162.41)	(165.97)	(115.69)	(168.27)		(156.3) pt
	ROIC	—	(1,867.15)	0.00	0.00	0.00	0.00	(679.23)	(475.71)	(298.97)	(286.27)		+1,580.9 pt
	ROE	—	(31.96)	(47.06)	(113.79)	(920.35)	(492.82)	(199.51)	(210.34)	(131.58)	(188.05)		(156.1) pt

Negative figures in brackets.

estimates

All 10 years →

Fundamentals updated 26 Oct 2026

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NSPR InspireMD, Inc.	$21.0M	— (loss-making)	— (loss-making)	−0.39% (below 0%: shrinking)	n/m	−26.00% (below 0%: shrinking)	(43.70%)	(815.64%)	Compare
PMI Flag Ship Acquisition Corp	$19.9M	— (loss-making)	— (loss-making)	+38.62% (above 0%: growing)	n/m	+46.79% (above 0%: growing)	20.85%	(156.70%)	Compare
HSCS HeartSciences Inc.	$17.9M	— (loss-making)	— (loss-making)	−46.15% (below 0%: shrinking)	n/m	+18.18% (above 0%: growing)	61.90%	(139,957.14%)	Compare
LFWD Lifeward Ltd.	$16.7M	— (loss-making)	— (loss-making)	+15.71% (above 0%: growing)	n/m	−52.77% (below 0%: shrinking)	40.90%	(62.69%)	Compare
ARAY Accuray Incorporated	$16.7M	— (loss-making)	— (loss-making)	−20.87% (below 0%: shrinking)	n/m	+117.83% (above 0%: growing)	35.22%	5.47%	Compare
ALUR Allurion Technologies, Inc.	$16.7M	— (loss-making)	— (loss-making)	−47.19% (below 0%: shrinking)	n/m	+65.98% (above 0%: growing)	41.70%	(126.60%)	Compare
MODD Modular Medical, Inc.	$16.3M	— (loss-making)	—	—	n/m	−5.61% (below 0%: shrinking)	0.00%	0.00%
PAVM PAVmed Inc.	$15.8M	— (loss-making)	— (loss-making)	+450.00% (above 0%: growing)	n/m	−125.63% (below 0%: shrinking)	(269.70%)	(21,278.79%)	Compare
CTSO Cytosorbents Corporation	$13.9M	— (loss-making)	— (loss-making)	+0.17% (above 0%: growing)	n/m	+64.90% (above 0%: growing)	73.18%	(27.39%)	Compare
Median of peers	$16.7M	—	—	−0.11%	—	+32.48%	38.06%	(141.65%)

All 149 Medical Devices stocks →

Pay and ownership Proxy statement filed 1 October 2026

Chief executive’s pay

Year	Total pay	Actually paid	$100 invested
2026	47.00k	17.06k	(90.49)

Ownership

Directors and executive officers, together 2.25%

AWM Investment Company 9.99%

Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement